DR. MICHAEL E KLEINBERG, M.D.
Osteopathic Medicine at Greene St, Baltimore, MD

License number
Maryland D33949
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
22 S Greene St, Baltimore, MD 21201
Phone
(410) 328-2679
(410) 328-6896 (Fax)

Personal information

See more information about MICHAEL E KLEINBERG at radaris.com
Name
Address
Phone
Michael Kleinberg
2009 Jolly Rd, Baltimore, MD 21209
Michael Kleinberg
2009 Jolly Rd, Baltimore, MD 21209

Organization information

See more information about MICHAEL E KLEINBERG at bizstanding.com

University Of Maryland - Michael E Kleinberg MD

22 S Greene St #1, Baltimore, MD 21201

Categories:
Internal Medicine Physicians & Surgeons
Phone:
(410) 328-7450 (Phone)

Professional information

Michael E Kleinberg Photo 1

Michael E Kleinberg, Baltimore MD

Specialties:
Infectious Disease Specialist
Address:
22 S Greene St, Baltimore, MD 21201
Education:
Yeshiva University, Albert Einstein College of Medicine - Doctor of Medicine
National Institutes of Health-Clinical Center - Fellowship - Infectious Disease (Internal Medicine)
New York Presbyterian Hospital/Weill Cornell Medical Center - Residency - Family Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Infectious Disease (Internal Medicine)


Michael E Kleinberg Photo 2

Dr. Michael E Kleinberg, Baltimore MD - MD (Doctor of Medicine)

Specialties:
Infectious Disease Medicine
Address:
UNIVERSITY OF MARYLAND MEDICAL CENTER
22 S Greene St, Baltimore 21201
(410) 328-6971 (Phone), (410) 328-8326 (Fax)
University Maryland Cancer Ctr
22 S Greene St SUITE 1, Baltimore 21201
(410) 328-7450 (Phone)
Certifications:
Infectious Disease, 2001, Internal Medicine, 1989
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
UNIVERSITY OF MARYLAND MEDICAL CENTER
22 S Greene St, Baltimore 21201
University Maryland Cancer Ctr
22 S Greene St SUITE 1, Baltimore 21201
Kernan Orthopaedics and Rehabilitation
2200 Kernan Dr, Baltimore 21207
Education:
Medical School
Albert Einstein College of Medicine of Yeshiva University
Graduated: 1984
Ny Hosp
National Institutes Of Health Clinical Center


Michael Eric Kleinberg Photo 3

Michael Eric Kleinberg, Baltimore MD

Specialties:
Internal Medicine, Infectious Disease, Hematology & Oncology, Medical Oncology, Transplant Surgery
Work:
University of Maryland
22 S Greene St, Baltimore, MD 21263 Univ. Of Md Medical Group
419 W Redwood St, Baltimore, MD 21201 Univ. Of Md Medical System
10 N Greene St, Baltimore, MD 21201
Education:
Yeshiva University (1984)


Michael Kleinberg Photo 4

Antiproliferative Factor From Patients With Interstitial Cystitis

US Patent:
5962645, Oct 5, 1999
Filed:
Oct 3, 1997
Appl. No.:
8/944202
Inventors:
Susan Keay - Ellicott City MD
John W. Warren - Baltimore MD
Michael Kleinberg - Baltimore MD
Michael K. Hise - Ellicott City MD
Assignee:
University of Maryland - Baltimore MD
International Classification:
C07K 100, C12G 100, G01N 33574
US Classification:
530350
Abstract:
A novel antiproliferative factor (APF) present in urine of patients with interstitial cystitis (IC) is described. This urine antiproliferative factor can serve as a marker for disease activity and its antagonists as therapeutic medicaments for IC. In addition, APF and its agonists can be used for treating diseases associated with cell proliferation.


Michael Kleinberg Photo 5

Antiproliferative Factor

US Patent:
2002001, Feb 7, 2002
Filed:
Apr 21, 2001
Appl. No.:
09/839859
Inventors:
Susan Keay - Ellicott City MD, US
John Warren - Baltimore MD, US
Michael Kleinberg - Baltimore MD, US
Michael Hise - Columbia MD, US
International Classification:
G01N033/53, G01N033/567, A61K039/395, C12N015/12, C12P021/00
US Classification:
530/350000, 424/130100, 435/007200, 514/002000, 536/023500
Abstract:
The invention relates to a novel antiproliferative factor (APF) present in urine of patients with interstitial cystitis (IC). APF is useful as a marker for disease activity and its antagonists are useful as therapeutic medicaments for IC and other conditions associated with elevated APF. APF and its agonists are useful in the treatment of diseases associated with cell proliferation, such as bladder cancer.